1. Home
  2. MRT vs AARD Comparison

MRT vs AARD Comparison

Compare MRT & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marti Technologies Inc.

MRT

Marti Technologies Inc.

HOLD

Current Price

$1.95

Market Cap

176.2M

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$5.30

Market Cap

165.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRT
AARD
Founded
2018
2017
Country
Turkey
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.2M
165.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
MRT
AARD
Price
$1.95
$5.30
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$3.58
$15.29
AVG Volume (30 Days)
46.0K
106.7K
Earning Date
08-08-2018
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.11
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$72.36
N/A
Revenue Next Year
$95.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$3.35
52 Week High
$2.75
$17.94

Technical Indicators

Market Signals
Indicator
MRT
AARD
Relative Strength Index (RSI) 64.77 44.11
Support Level $1.99 $5.12
Resistance Level $2.29 $6.43
Average True Range (ATR) 0.13 0.81
MACD 0.01 -0.14
Stochastic Oscillator 92.73 22.17

Price Performance

Historical Comparison
MRT
AARD

About MRT Marti Technologies Inc.

Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: